Busen Wang

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Respiratory Syndrome Coronavirus

Inflammatory Response

Top Venues

Signal transduction and targeted therapy

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Busen Wang, Jinghan Xu, Shipo Wu, Zhe Zhang, Zhenghao Zhao, Jun Zhang, Ling Fu, Xiaodong Zai, Yudong Wang, Guanying Zhang, ZhengShan Chen, Yi Chen, Hancong Sun, Xiaohong Song, Jinlong Zhang, Lianhui Zhu, Lihua Hou, Wei Chen
Comparative characterization of antibody responses induced by Ad5-vectored spike proteins of emerging SARS-CoV-2 VOCs. Signal transduction and targeted therapy 7 (1) (2022)
Xiangyang Chi, Yingying Guo, Guanying Zhang, Hancong Sun, Jun Zhang, Min Li, Zhengshan Chen, Jin Han, Yuanyuan Zhang, Xinghai Zhang, Pengfei Fan, Zhe Zhang, Busen Wang, Xiaodong Zai, Xuelian Han, Meng Hao, Ting Fang, Jinghan Xu, Shipo Wu, Yi Chen, Yingying Fang, Yunzhu Dong, Bingjie Sun, Jinlong Zhang, Jianmin Li, Guangyu Zhao, Changming Yu, Qiang Zhou, Wei Chen
Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination. Signal transduction and targeted therapy 7 (1) (2022)
Shipo Wu, Gongxun Zhong, Jun Zhang, Lei Shuai, Zhe Zhang, Zhiyuan Wen, Busen Wang, Zhenghao Zhao, Xiaohong Song, Yi Chen, Renqiang Liu, Ling Fu, Jin-Long Zhang, Qiang Guo, Chong Wang, Yilong Yang, Ting Fang, Peng Lv, Jinliang Wang, Junjie Xu, Jianmin Li, Changming Yu, Li-Hua Hou, Zhi-Gao Bu, Wei Chen
A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge. Nature communications 11 (1) (2020)